Timsans, J.; Kauppi, J.; Rantalaiho, V.; Kerola, A.; Hakkarainen, K.; Paldanius, M.; Kautiainen, H.; Kauppi, M.
Hyperuricemia—Especially “Metabolic Hyperuricemia”—Is Independently Associated with a Higher Risk of Steatotic Liver Disease. Metabolites 2025, 15, 356.
https://doi.org/10.3390/metabo15060356
AMA Style
Timsans J, Kauppi J, Rantalaiho V, Kerola A, Hakkarainen K, Paldanius M, Kautiainen H, Kauppi M.
Hyperuricemia—Especially “Metabolic Hyperuricemia”—Is Independently Associated with a Higher Risk of Steatotic Liver Disease. Metabolites. 2025; 15(6):356.
https://doi.org/10.3390/metabo15060356
Chicago/Turabian Style
Timsans, Janis, Jenni Kauppi, Vappu Rantalaiho, Anne Kerola, Kia Hakkarainen, Mika Paldanius, Hannu Kautiainen, and Markku Kauppi.
2025. "Hyperuricemia—Especially “Metabolic Hyperuricemia”—Is Independently Associated with a Higher Risk of Steatotic Liver Disease" Metabolites 15, no. 6: 356.
https://doi.org/10.3390/metabo15060356
APA Style
Timsans, J., Kauppi, J., Rantalaiho, V., Kerola, A., Hakkarainen, K., Paldanius, M., Kautiainen, H., & Kauppi, M.
(2025). Hyperuricemia—Especially “Metabolic Hyperuricemia”—Is Independently Associated with a Higher Risk of Steatotic Liver Disease. Metabolites, 15(6), 356.
https://doi.org/10.3390/metabo15060356
